Home > > > Report Detail

Global Sphingosine 1-Phosphate Receptor 1 Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 03-Oct-2022
No. of pages: 83
Inquire Before Buying

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Sphingosine 1-Phosphate Receptor 1 market is projected to reach US$ 5998.4 million by 2028 from an estimated US$ 3697.1 million in 2022, at a CAGR of 8.4% during 2023 and 2028.

In the last several years, global market of Sphingosine 1-Phosphate Receptor 1 developed rapidly, with an average growth rate of 3.5%, Sphingosine 1-Phosphate Receptor 1 is widely used in Hospital, Clinic. North America is the largest consumption place, with a revenue market share nearly 57.1% in 2019,. and market competition is not intense.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sphingosine 1-Phosphate Receptor 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Sphingosine 1-Phosphate Receptor 1.

The Sphingosine 1-Phosphate Receptor 1 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Sphingosine 1-Phosphate Receptor 1 market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sphingosine 1-Phosphate Receptor 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Novartis AG

- Bristol-Myers Squibb Company

Product Type Insights

Global markets are presented by Sphingosine 1-Phosphate Receptor 1 type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Sphingosine 1-Phosphate Receptor 1 are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Sphingosine 1-Phosphate Receptor 1 Segment by Type

- Fingolimod

- Siponimod

- Ozanimod

- Other

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Sphingosine 1-Phosphate Receptor 1 market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Sphingosine 1-Phosphate Receptor 1 market.

Sphingosine 1-Phosphate Receptor 1 Segment by Application

- Hospital

- Clinic

- Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Sphingosine 1-Phosphate Receptor 1 market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sphingosine 1-Phosphate Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Sphingosine 1-Phosphate Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Sphingosine 1-Phosphate Receptor 1 industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sphingosine 1-Phosphate Receptor 1

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Sphingosine 1-Phosphate Receptor 1 Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Sphingosine 1-Phosphate Receptor 1 Product Introduction
1.2 Market by Type
1.2.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Fingolimod
1.2.3 Siponimod
1.2.4 Ozanimod
1.2.5 Other
1.3 Market by Application
1.3.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size Estimates and Forecasts
2.1.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue 2017-2028
2.1.2 Global Sphingosine 1-Phosphate Receptor 1 Sales 2017-2028
2.2 Sphingosine 1-Phosphate Receptor 1 Market Size by Region: 2022 Versus 2028
2.3 Sphingosine 1-Phosphate Receptor 1 Sales by Region (2017-2028)
2.3.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region: 2017-2022
2.3.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Region (2023-2028)
2.3.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Region (2017-2028)
2.4 Sphingosine 1-Phosphate Receptor 1 Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region: 2017-2022
2.4.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Region (2023-2028)
2.4.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Region (2017-2028)
3 Global Sphingosine 1-Phosphate Receptor 1 by Manufacturers
3.1 Global Top Sphingosine 1-Phosphate Receptor 1 Manufacturers by Sales
3.1.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Manufacturer (2017-2022)
3.1.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Sphingosine 1-Phosphate Receptor 1 Manufacturers by Revenue
3.2.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Manufacturer (2017-2022)
3.2.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Share by Manufacturer (2017-2022)
3.3 Global Sphingosine 1-Phosphate Receptor 1 Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Sphingosine 1-Phosphate Receptor 1 Manufacturers Covered: Ranking by Revenue
3.4.2 Global Sphingosine 1-Phosphate Receptor 1 Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Sphingosine 1-Phosphate Receptor 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Sphingosine 1-Phosphate Receptor 1 Manufacturing Base Distribution, Product Type
3.5.1 Sphingosine 1-Phosphate Receptor 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Sphingosine 1-Phosphate Receptor 1 Product Type
3.5.3 Date of International Manufacturers Enter into Sphingosine 1-Phosphate Receptor 1 Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novartis AG
4.1.1 Novartis AG Corporation Information
4.1.2 Novartis AG Description, Business Overview
4.1.3 Novartis AG Sphingosine 1-Phosphate Receptor 1 Products Offered
4.1.4 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales by Product in 2021
4.1.6 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales by Application in 2021
4.1.7 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales by Geographic Area in 2021
4.1.8 Novartis AG Recent Developments
4.2 Bristol-Myers Squibb Company
4.2.1 Bristol-Myers Squibb Company Corporation Information
4.2.2 Bristol-Myers Squibb Company Description, Business Overview
4.2.3 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Products Offered
4.2.4 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales by Product in 2021
4.2.6 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales by Application in 2021
4.2.7 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales by Geographic Area in 2021
4.2.8 Bristol-Myers Squibb Company Recent Developments
5 Breakdown Data by Type
5.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2028)
5.1.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2022)
5.1.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Type (2023-2028)
5.1.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2017-2028)
5.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Type (2017-2028)
5.2.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2017-2022)
5.2.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Type (2023-2028)
5.2.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Type (2017-2028)
5.3 Sphingosine 1-Phosphate Receptor 1 Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2028)
6.1.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2022)
6.1.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Application (2023-2028)
6.1.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2017-2028)
6.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Application (2017-2028)
6.2.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2017-2022)
6.2.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Application (2023-2028)
6.2.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Application (2017-2028)
6.3 Sphingosine 1-Phosphate Receptor 1 Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Sphingosine 1-Phosphate Receptor 1 Market Size YoY Growth 2017-2028
7.2 North America Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country
7.2.1 North America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2028)
7.2.2 North America Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2028)
7.3 North America Sphingosine 1-Phosphate Receptor 1 Sales by Type
7.4 North America Sphingosine 1-Phosphate Receptor 1 Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Region
8.2.1 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Region (2017-2028)
8.2.2 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2017-2028)
8.3 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Type
8.4 Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Application
9 Europe
9.1 Europe Sphingosine 1-Phosphate Receptor 1 Market Size YoY Growth 2017-2028
9.2 Europe Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country
9.2.1 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2028)
9.2.2 Europe Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2028)
9.3 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Type
9.4 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Application
10 Latin America
10.1 Latin America Sphingosine 1-Phosphate Receptor 1 Market Size YoY Growth 2017-2028
10.2 Latin America Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country
10.2.1 Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2028)
10.2.2 Latin America Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2028)
10.3 Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Type
10.4 Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Market Facts & Figures by Country
11.2.1 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2028)
11.2.2 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2028)
11.3 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Type
11.4 Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Sphingosine 1-Phosphate Receptor 1 Supply Chain Analysis
12.2 Sphingosine 1-Phosphate Receptor 1 Key Raw Materials and Upstream Suppliers
12.3 Sphingosine 1-Phosphate Receptor 1 Clients Analysis
12.4 Sphingosine 1-Phosphate Receptor 1 Sales Channel and Sales Model Analysis
12.4.1 Sphingosine 1-Phosphate Receptor 1 Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Sphingosine 1-Phosphate Receptor 1 Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Sphingosine 1-Phosphate Receptor 1 Distributors
13 Market Dynamics
13.1 Sphingosine 1-Phosphate Receptor 1 Industry Trends
13.2 Sphingosine 1-Phosphate Receptor 1 Market Drivers
13.3 Sphingosine 1-Phosphate Receptor 1 Market Challenges
13.4 Sphingosine 1-Phosphate Receptor 1 Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Sphingosine 1-Phosphate Receptor 1 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Fingolimod
Table 3. Major Manufacturers of Siponimod
Table 4. Major Manufacturers of Ozanimod
Table 5. Major Manufacturers of Other
Table 6. Global Sphingosine 1-Phosphate Receptor 1 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Sphingosine 1-Phosphate Receptor 1 Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 8. Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2017-2022) & (K Units)
Table 9. Global Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Region (2023-2028) & (K Units)
Table 10. Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 12. Global Sphingosine 1-Phosphate Receptor 1 Sales by Manufacturer (2017-2022) & (K Units)
Table 13. Global Sphingosine 1-Phosphate Receptor 1 Sales Share by Manufacturer (2017-2022)
Table 14. Sphingosine 1-Phosphate Receptor 1 Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 15. Sphingosine 1-Phosphate Receptor 1 Revenue Share by Manufacturer (2017-2022)
Table 16. Key Manufacturers Sphingosine 1-Phosphate Receptor 1 Price (2017-2022) & (US$/Unit)
Table 17. Ranking of Global Top Sphingosine 1-Phosphate Receptor 1 Manufacturers by Revenue (US$ Million) in 2021
Table 18. Global Sphingosine 1-Phosphate Receptor 1 Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 19. Global Sphingosine 1-Phosphate Receptor 1 by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sphingosine 1-Phosphate Receptor 1 as of 2021)
Table 20. Sphingosine 1-Phosphate Receptor 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Sphingosine 1-Phosphate Receptor 1 Product Type
Table 22. Date of International Manufacturers Enter into Sphingosine 1-Phosphate Receptor 1 Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Novartis AG Corporation Information
Table 25. Novartis AG Description and Business Overview
Table 26. Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 27. Novartis AG Sphingosine 1-Phosphate Receptor 1 Product
Table 28. Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales Proportion of Sphingosine 1-Phosphate Receptor 1 by Product in 2021
Table 29. Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales Proportion of Sphingosine 1-Phosphate Receptor 1 by Application in 2021
Table 30. Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales Proportion of Sphingosine 1-Phosphate Receptor 1 by Geographic Area in 2021
Table 31. Novartis AG Recent Development
Table 32. Bristol-Myers Squibb Company Corporation Information
Table 33. Bristol-Myers Squibb Company Description and Business Overview
Table 34. Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 35. Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Product
Table 36. Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales Proportion of Sphingosine 1-Phosphate Receptor 1 by Product in 2021
Table 37. Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales Proportion of Sphingosine 1-Phosphate Receptor 1 by Application in 2021
Table 38. Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales Proportion of Sphingosine 1-Phosphate Receptor 1 by Geographic Area in 2021
Table 39. Bristol-Myers Squibb Company Recent Development
Table 40. Global Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2022) & (K Units)
Table 41. Global Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Type (2023-2028) & (K Units)
Table 42. Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2017-2022) & (US$ Million)
Table 43. Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 44. Global Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2022) & (K Units)
Table 45. Global Sphingosine 1-Phosphate Receptor 1 Sales Forecast by Application (2023-2028) & (K Units)
Table 46. Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Sphingosine 1-Phosphate Receptor 1 Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 48. North America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2022) & (K Units)
Table 49. North America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2023-2028) & (K Units)
Table 50. North America Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 51. North America Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 52. North America Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2022) & (K Units)
Table 53. North America Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2022) & (K Units)
Table 54. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2017-2028) & (US$ Million)
Table 57. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2023-2028) & (US$ Million)
Table 58. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2022) & (K Units)
Table 60. Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2022) & (K Units)
Table 61. Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country (2023-2028) & (K Units)
Table 62. Europe Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 63. Europe Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2022) & (K Units)
Table 65. Europe Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2022) & (K Units)
Table 66. Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2022) & (K Units)
Table 67. Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2023-2028) & (K Units)
Table 68. Latin America Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 69. Latin America Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 70. Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2022) & (K Units)
Table 71. Latin America Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2022) & (K Units)
Table 72. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Country (2017-2022) & (K Units)
Table 73. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Country (2023-2028) & (K Units)
Table 74. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 75. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 76. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Type (2017-2022) & (K Units)
Table 77. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales by Application (2017-2022) & (K Units)
Table 78. Sphingosine 1-Phosphate Receptor 1 Key Raw Materials, Industry Status and Trend
Table 79. Sphingosine 1-Phosphate Receptor 1 Key Raw Materials and Upstream Suppliers
Table 80. Sphingosine 1-Phosphate Receptor 1 Clients Status and Trend
Table 81. Sphingosine 1-Phosphate Receptor 1 Typical Clients
Table 82. Sphingosine 1-Phosphate Receptor 1 Distributors
Table 83. Sphingosine 1-Phosphate Receptor 1 Market Trends
Table 84. Sphingosine 1-Phosphate Receptor 1 Market Drivers
Table 85. Sphingosine 1-Phosphate Receptor 1 Market Challenges
Table 86. Sphingosine 1-Phosphate Receptor 1 Market Restraints
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Sphingosine 1-Phosphate Receptor 1 Product Picture
Figure 2. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type in 2021 & 2028
Figure 3. Fingolimod Product Picture
Figure 4. Siponimod Product Picture
Figure 5. Ozanimod Product Picture
Figure 6. Other Product Picture
Figure 7. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application in 2021 & 2028
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Sphingosine 1-Phosphate Receptor 1 Report Years Considered
Figure 12. Global Sphingosine 1-Phosphate Receptor 1 Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Sphingosine 1-Phosphate Receptor 1 Market Size 2017-2028 (US$ Million)
Figure 14. Global Sphingosine 1-Phosphate Receptor 1 Sales 2017-2028 (K Units)
Figure 15. Global Sphingosine 1-Phosphate Receptor 1 Market Size Market Share by Region: 2022 Versus 2028
Figure 16. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share Forecast by Region (2017-2028)
Figure 17. Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Region (2017-2028)
Figure 18. Global Sphingosine 1-Phosphate Receptor 1 Sales Share by Manufacturer in 2021
Figure 19. Sphingosine 1-Phosphate Receptor 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share Forecast by Type (2017-2028)
Figure 21. Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share Forecast by Type (2017-2028)
Figure 22. Sphingosine 1-Phosphate Receptor 1 Average Selling Price (ASP) by Type (2017-2022) & (US$/Unit)
Figure 23. Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share Forecast by Application (2017-2028)
Figure 24. Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share Forecast by Application (2017-2028)
Figure 25. Sphingosine 1-Phosphate Receptor 1 Average Selling Price (ASP) by Application (2017-2022) & (US$/Unit)
Figure 26. North America Sphingosine 1-Phosphate Receptor 1 Revenue 2017-2028 (US$ Million)
Figure 27. North America Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2017-2022)
Figure 28. North America Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2017-2022)
Figure 29. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Revenue 2017-2028 (US$ Million)
Figure 30. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2017-2022)
Figure 33. Asia-Pacific Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2017-2022)
Figure 34. Europe Sphingosine 1-Phosphate Receptor 1 Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Europe Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Country (2017-2028)
Figure 36. Europe Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Country (2017-2028)
Figure 37. Europe Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2017-2022)
Figure 38. Europe Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2017-2022)
Figure 39. Latin America Sphingosine 1-Phosphate Receptor 1 Revenue Growth Rate 2017-2028 (US$ Million)
Figure 40. Latin America Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Country (2017-2028)
Figure 41. Latin America Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Country (2017-2022)
Figure 42. Latin America Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2017-2022)
Figure 43. Latin America Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2017-2022)
Figure 44. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue Growth Rate 2017-2028 (US$ Million)
Figure 45. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2017-2022)
Figure 48. Middle East and Africa Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2017-2022)
Figure 49. Sphingosine 1-Phosphate Receptor 1 Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Sphingosine 1-Phosphate Receptor 1 Raw Materials by Region in 2021
Figure 51. Sphingosine 1-Phosphate Receptor 1 Distribution Channels
Figure 52. Global Sphingosine 1-Phosphate Receptor 1 Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 53. Global Sphingosine 1-Phosphate Receptor 1 Percentage 2017-2028: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs